Cancer.
Insights.
Cures.
Aster Insights partners with drug, biologics, diagnostics, and medical device developers to accelerate oncology product discovery and development through our scientific and clinical intelligence.
Together we can make an impact.
A growing foundation of nearly half a million patients as partners
Multimodal scientific and clinical intelligence
Forward-thinking, patient-focused research
Novel insights for tomorrow's cures
Together, we are changing the way cancer is studied, treated, and prevented
OUR HISTORY
Long-Time Innovator in Oncology
2006
M2GEN (now Aster Insights) is founded. First patient enrolled in Total Cancer Care®
2012
Merck uses our data to lay path for KEYTRUDA® development
2014
Oncology Research Information Exchange Network (ORIEN®) consortium established
2018
ORIEN® expands and adds community partnership
2021
Exceeded 100 publications from Total Cancer Care®
2022
Exceeded 150 cumulative ORIEN® research collaborations
2024
400,000 patients accrued in TCC®